Insider Stock Trading History of Horak Ivan D


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Horak Ivan D since year 2005. The trader's CIK number is 1247903. At the time of this reporting, Horak Ivan D is the EVP, R&D, Chief Scie of Enzon Pharmaceuticals Inc . (stock ticker symbol ENZN). See this page for all insider trading activities at Enzon Pharmaceuticals Inc .


Stock purchases, sales, and option exercises reported by insider Horak Ivan D since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2011-04-03 ENZN Enzon Pharmaceuticals Inc Option Ex 26,480 .00 0
2010-11-23 ENZN Enzon Pharmaceuticals Inc Option Ex 3,000 .00 0
2010-09-17 ENZN Enzon Pharmaceuticals Inc Sale 200,000 10.63 2,126,600
2010-09-16 ENZN Enzon Pharmaceuticals Inc Sale 1,700 10.67 18,132
2010-09-17 ENZN Enzon Pharmaceuticals Inc Option Ex 242,000 7.27 1,759,340
2010-09-15 ENZN Enzon Pharmaceuticals Inc Sale 57,200 10.81 618,217
2010-09-16 ENZN Enzon Pharmaceuticals Inc Option Ex 2,000 7.14 14,280
2010-09-15 ENZN Enzon Pharmaceuticals Inc Option Ex 70,200 7.06 495,261
2010-09-02 ENZN Enzon Pharmaceuticals Inc Option Ex 20,000 .00 0
2010-04-03 ENZN Enzon Pharmaceuticals Inc Option Ex 19,860 .00 0
2010-02-22 ENZN Enzon Pharmaceuticals Inc Sale 101,329 9.32 944,284
2009-11-23 ENZN Enzon Pharmaceuticals Inc Option Ex 2,250 .00 0
2009-09-02 ENZN Enzon Pharmaceuticals Inc Option Ex 15,000 .00 0
2009-04-03 ENZN Enzon Pharmaceuticals Inc Option Ex 19,860 .00 0
2009-04-03 ENZN Enzon Pharmaceuticals Inc Sale 7,035 6.12 43,054
2008-11-23 ENZN Enzon Pharmaceuticals Inc Option Ex 2,250 .00 0
2008-09-02 ENZN Enzon Pharmaceuticals Inc Option Ex 15,000 .00 0
2006-03-07 ENZN Enzon Pharmaceuticals Inc Buy 3,000 6.87 20,604
2006-03-07 ENZN Enzon Pharmaceuticals Inc Buy 3,000 6.87 20,604
2005-10-04 ENZN Enzon Pharmaceuticals Inc Buy 5,500 7.18 39,490

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Horak Ivan D (EVP, R&D, Chief Scie of Enzon Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.